Metraipolis › archive › dc_2e285ac120f3

Berberine protects against gefitinib-induced liver injury by inhibiting the HMGB1/TLR4/NF-κB pathway — Europe PMC PMID:40932871

Source
Europe PMC (en)
Original
https://europepmc.org/article/MED/40932871
DOI
10.3389/fphar.2025.1645634
License (as archived)
solo-consultazione
Archived
2026-11-10T08:19:27.191Z
SHA-256 of the archived text
cbe7e7b8b5f4b0227ac0b52c5a4b655de2fb4b811774137fc42e3ed951f14eb9
Stable URL of this page
https://metraipolis.com/documento/dc_2e285ac120f3

How to cite

Berberine protects against gefitinib-induced liver injury by inhibiting the HMGB1/TLR4/NF-κB pathway — Europe PMC PMID:40932871 — Europe PMC (en), https://europepmc.org/article/MED/40932871 (solo-consultazione); archived copy: https://metraipolis.com/documento/dc_2e285ac120f3 (Metraipolis archive dc_2e285ac120f3, sha256 cbe7e7b8b5f4b0227ac0b52c5a4b655de2fb4b811774137fc42e3ed951f14eb9)
BibTeX
@misc{dc2e285ac120f3,
  title = {Berberine protects against gefitinib-induced liver injury by inhibiting the HMGB1/TLR4/NF-κB pathway — Europe PMC PMID:40932871},
  howpublished = {Europe PMC (en)},
  url = {https://europepmc.org/article/MED/40932871},
  note = {License solo-consultazione; archived copy https://metraipolis.com/documento/dc_2e285ac120f3; sha256 cbe7e7b8b5f4b0227ac0b52c5a4b655de2fb4b811774137fc42e3ed951f14eb9},
  year = {2026}
}

Archived text

The text is not reproduced here: the archive holds it as solo-consultazione (consultation only, no republication). Read it at the original source: https://europepmc.org/article/MED/40932871. Agents can read the archived copy with the MCP tool read_document.